{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:55:05Z","timestamp":1768510505906,"version":"3.49.0"},"reference-count":22,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2007,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Herpes B virus (B virus [BV]) is a macaque herpesvirus that is occasionally transmitted to humans where it can cause rapidly ascending encephalitis that is often fatal. To understand the low susceptibility of BV to the acyclonucleosides, we have cloned, expressed, and characterized the BV thymidine kinase (TK), an enzyme that is expected to \u201cactivate\u201d nucleoside analogs. This enzyme is similar in sequence and properties to the TK of herpes simplex virus (HSV), i.e., it has a broad substrate range and low enantioselectivity and is sensitive to inhibitors of HSV TKs. The BV enzyme phosphorylates some modified nucleosides and acyclonucleosides and\n            <jats:sc>l<\/jats:sc>\n            enantiomers of thymidine and related antiherpetic analogs. However, the potent anti-HSV drugs acyclovir (ACV), ganciclovir (GCV), and 5-bromovinyldeoxyuridine were poorly or not phosphorylated by the BV enzyme under the experimental conditions. The antiviral activities of a number of marketed antiherpes drugs and experimental compounds were compared against BV strains and, for comparison, HSV type 1 (HSV-1) in Vero cell cultures. For most compounds tested, BV was found to be about as sensitive as HSV-1 was. However, BV was less sensitive to ACV and GCV than HSV-1 was. The abilities of thymidine analogs and acyclonucleosides to inhibit replication of BV in Vero cell culture were not always proportional to their substrate properties for BV TK. Our studies characterize BV TK for the first time and suggest new lead compounds, e.g., 5-ethyldeoxyuridine and pencyclovir, which may be superior to ACV or GCV as treatment for this emerging infectious disease.\n          <\/jats:p>","DOI":"10.1128\/aac.01284-06","type":"journal-article","created":{"date-parts":[[2007,4,17]],"date-time":"2007-04-17T00:38:55Z","timestamp":1176770335000},"page":"2028-2034","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":18,"title":["Sensitivity of Monkey B Virus (\n            <i>Cercopithecine herpesvirus<\/i>\n            1) to Antiviral Drugs: Role of Thymidine Kinase in Antiviral Activities of Substrate Analogs and Acyclonucleosides"],"prefix":"10.1128","volume":"51","author":[{"given":"Federico","family":"Focher","sequence":"first","affiliation":[{"name":"Istituto di Genetica Molecolare, Consiglio Nazionale delle Ricerche, 27100 Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Lossani","sequence":"additional","affiliation":[{"name":"Istituto di Genetica Molecolare, Consiglio Nazionale delle Ricerche, 27100 Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Verri","sequence":"additional","affiliation":[{"name":"Istituto di Genetica Molecolare, Consiglio Nazionale delle Ricerche, 27100 Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvio","family":"Spadari","sequence":"additional","affiliation":[{"name":"Istituto di Genetica Molecolare, Consiglio Nazionale delle Ricerche, 27100 Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Maioli","sequence":"additional","affiliation":[{"name":"GLSynthesis Inc., Worcester, Massachusetts 01605"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J.","family":"Gambino","sequence":"additional","affiliation":[{"name":"GLSynthesis Inc., Worcester, Massachusetts 01605"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George E.","family":"Wright","sequence":"additional","affiliation":[{"name":"GLSynthesis Inc., Worcester, Massachusetts 01605"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Eberle","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pathobiology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, Oklahoma 74078"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darla H.","family":"Black","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pathobiology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, Oklahoma 74078"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Medveczky","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, College of Medicine, University of South Florida, Tampa, Florida 33620"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Medveczky","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, College of Medicine, University of South Florida, Tampa, Florida 33620"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Shugar","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry and Biophysics, Polish Academy of Sciences, 02-106 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.280.6215.681"},{"key":"e_1_3_2_3_2","first-page":"230","volume":"20","year":"1981","unstructured":"Cheng, Y.-C., G. Dutschman, E. DeClercq, E. A. Jones, S. G. Rahim, G. Verhelst, and R. T. Walker. 1981. Differential affinities of 5-(2-halogenovinyl)-2\u2032-deoxyuridines for deoxythymidine kinases of various origins. Mol. Pharmacol.20:230-233.","journal-title":"Mol. Pharmacol."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/344754"},{"key":"e_1_3_2_5_2","first-page":"140","year":"1979","unstructured":"Davis, W. B., J. E. Oakes, J. P. Vacik, R. R. Rebert, and J. A. Taylor. 1979. 5-Ethyl-2\u2032-deoxyuridine as a systemic agent for treatment of herpes simplex virus encephalitis. Comparison of effects in a normal and immunosuppressed murine model, p. 140-150. In K. K. Gauri (ed.), Anti-herpesvirus chemotherapy: experimental and clinical aspects. Karger, Basel, Switzerland.","journal-title":"Anti-herpesvirus chemotherapy: experimental and clinical aspects."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.13.3.545"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(84)90649-X"},{"key":"e_1_3_2_8_2","first-page":"134","year":"1979","unstructured":"Elze, K.-L. 1979. Ten years of clinical experiences with ethyldeoxyuridine, p. 134-139. In K. K. Gauri (ed.), Anti-herpesvirus chemotherapy: experimental and clinical aspects. Karger, Basel, Switzerland.","journal-title":"Anti-herpesvirus chemotherapy: experimental and clinical aspects."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.2174\/1568005033342163"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(81)90495-0"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(83)90028-1"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.4.598"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2940381"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm049059x"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-003-0011-2"},{"key":"e_1_3_2_16_2","first-page":"246","volume":"55","year":"2005","unstructured":"Ritchey, J. W., M. E. Payton, and R. Eberle. 2005. Clinicopathological characterization of monkey B virus (Cercopithecine herpesvirus 1) infection in mice. Comp. Med.55:246-250.","journal-title":"Comp. Med."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00100a029"},{"key":"e_1_3_2_18_2","first-page":"1231","volume":"47","year":"1995","unstructured":"Spadari, S., G. Ciarrocchi, F. Focher, A. Verri, G. Maga, F. Arcamone, E. Iafrate, S. Manzini, A. Garbesi, and L. Tondelli. 1995. 5-Iodo-2\u2032-deoxy-L-uridine (L-IdU) and (E)-5-(2-bromovinyl)-2\u2032-deoxy-l-uridine (L-BVdU): selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity and cytotoxicity studies. Mol. Pharmacol.47:1231-1238.","journal-title":"Mol. Pharmacol."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00303a617"},{"key":"e_1_3_2_20_2","first-page":"2623","year":"1996","unstructured":"Whitley, R. J. 1996. Cercopithecine herpes virus 1 (B virus), p. 2623-2635. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott Raven, Philadelphia, PA.","journal-title":"Fields virology"},{"key":"e_1_3_2_21_2","first-page":"447","volume":"47","year":"1990","unstructured":"Wright, G. E., and N. C. Brown. 1990. Deoxyribonucleotide analogs as inhibitors and substrates of DNA polymerases. Pharm. Ther.47:447-497.","journal-title":"Pharm. Ther."},{"key":"e_1_3_2_22_2","first-page":"541","volume":"1","year":"1999","unstructured":"Wright, G. E., J. J. Gambino, H. Sun, and B. M. Gebhardt. 1999. Status of inhibitors of herpes simplex thymidine kinase. Curr. Opin. Anti-infect. Drugs1:541-546.","journal-title":"Curr. Opin. Anti-infect. Drugs"},{"key":"e_1_3_2_23_2","first-page":"87","volume":"38","year":"1995","unstructured":"Xu, H., G. Maga, F. Focher, E. R. Smith, S. Spadari, J. Gambino, and G. E. Wright. 1995. Synthesis, properties and pharmacokinetic studies of N2-phenylguanine derivatives as inhibitors of herpes simplex virus thymidine kinases. J. Med. Chem.38:87-94.","journal-title":"J. Med. Chem."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01284-06","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01284-06","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T19:24:30Z","timestamp":1645471470000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01284-06"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["10.1128\/AAC.01284-06"],"URL":"https:\/\/doi.org\/10.1128\/aac.01284-06","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6]]},"assertion":[{"value":"2006-10-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-03-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}